G Medical Innovations Holdings Ltd
GMVDF
$0.0002
$0.000.00%
| 12/31/2022 | 09/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -1.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -1.26% | |||
| Cost of Revenue | 0.00% | -149.08% | |||
| Gross Profit | 0.00% | 215.94% | |||
| SG&A Expenses | 0.00% | -23.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -61.69% | |||
| Operating Income | 0.00% | 68.15% | |||
| Income Before Tax | 0.00% | 94.97% | |||
| Income Tax Expenses | 0.00% | -76.92% | |||
| Earnings from Continuing Operations | 0.00% | 94.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -35.71% | |||
| Net Income | 0.00% | 96.16% | |||
| EBIT | 0.00% | 68.15% | |||
| EBITDA | 0.00% | 67.87% | |||
| EPS Basic | 0.00% | 97.87% | |||
| Normalized Basic EPS | 0.00% | 98.30% | |||
| EPS Diluted | 0.00% | 97.87% | |||
| Normalized Diluted EPS | 0.00% | 98.30% | |||
| Average Basic Shares Outstanding | 0.00% | 80.23% | |||
| Average Diluted Shares Outstanding | 0.00% | 80.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
